Cost effectiveness analysis of using quantitative ultrasound as a selective pre-screen for bone densitometry

Technology and Health Care

Volumn 13, Issue 2, 2005, Pages 75-85

  Sim, M F V ^a   Stone, M D ^a   Phillips, C J ^b   Cheung, W Y ^b   Johansen, A ^a   Vasishta, S ^a   Pettit, R J ^c   Evans, W D ^c  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b SWANSEA UNIVERSITY   (United Kingdom)

^c UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BONE DENSITOMETRY; BONE DENSITY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST MINIMIZATION ANALYSIS; COST OF ILLNESS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GENERAL PRACTITIONER; HEEL; HIP; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; PATIENT REFERRAL; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; SAMPLE SIZE; SCREENING TEST;

EID: 21044458747     PISSN: 09287329     EISSN: None     Source Type: Journal    
DOI: 10.3233/thc-2005-13201     Document Type: Article

References (24)

1. P. Dolan and D.J. Torgerson, The cost of treating osteoporotic fractures in the United Kingdom female population, Osteoporosis International 8 (1998), 611-617.
2. National Osteoporosis Society, Foreword to Osteoporosis Framework, NOS, Bath, http://www.nos.org.uk/framework
3. W. Hollingworth, C.J. Todd and M.J. Parker, The cost of treating hip fractures in the twenty-first century: short report, Osteoporosis International 6(Suppl 2) (1996), 13-15.
4. N. Zethraeus, W. Ben Sedrine, F. Caulin et al., Models for assessing the cost-effectiveness of the treatment and prevention of osteoporosis, Osteoporosis International 13 (2002), 841-857.
5. O. Johnell, The socioeconomic burden of fractures: today and in the 21st century, American Journal of Medicine 103(A) (1997), 20S-25S.
6. D.J. Torgerson, C.P. Iglesias and D.M. Reid, The economics of fracture prevention, in: The Effective Management of Osteoporosis, D.H. Barlow, ed., Aesculapius Medical Press, London, 2001, pp. 111-121.
7. National Osteoporosis Society, Press Release, £20 billion - cost of treating osteoporosis in the next ten years, NOS, Bath, 2001.
8. The WHO study group, Assessment of fracture risk and its application to screening for postmenopausal osteoporosis, World Health Organisation, Geneva, 1994.
9. P.D. Miller, S.L. Bonnick and C.J. Rosen, Consensus of an international panel on the clinical utility of bone mass measurements in the detection of low bone mass in the adult population, Calcified Tissue International 58 (1996), 207-214.
10. J.E. Compston, C. Cooper and J.A. Kanis, Bone densitometry in clinical practice, British Medical Journal 310 (1995), 1507-1510.
11. C.C. Gluer and R. Barkmann, Quantitative ultrasound - sound utility, in: Current Research in Osteoporosis and Bone Mineral Measurement V, E.F.J. Ring, D.M. Elvins DM and A.K. Bhalla, eds, British Institute of Radiology, London, 1998, pp. 55-57.
12. D. Hans, P. Dargent-Molina, A.M. Schott et al., Ultrasonographic heel measurements to predict hip fracture in elderly women: the EPIDOS prospective study, Lancet 348 (1996), 511-514.
13. P. Thompson, J. Taylor, A. Fisher and R. Oliver, Quantitative heel ultrasound in 3180 women between 45 and 75 years of age: compliance, normal ranges and relationship to fracture history, Osteoporosis International 8 (1998), 211-214.
14. C.M. Langton, S.B. Palmer and R.W. Porter, The measurement of broadband ultrasound attenuation in cancellous bone, Engineering in Medicine 13 (1984), 89-91.
15. C.F. Njeh, T. Fuerst, E. Diessel and H.K. Genant, Is quantitative ultrasound dependent on bone structure? A reflection, Osteoporosis International 12 (2001), 1-15.
16. C.F. Njeh, C.M. Boivin and C.M. Langton, The role of ultrasound in the management of osteoporosis: a review, Osteoporosis International 7 (1997), 7-22.
17. M.J. Campbell and D. Machin, Medical Statistics: A Commonsense Approach, John Wiley and Sons, Chichester, 1999.
18. M. Gardner and D. Altman, Statistics with Confidence, British Medical Journal Publishing, London, 1989.
19. C.M. Langton, P.A. Ballard, D.K. Langton and D.W. Purdie, Maximising the cost effectiveness of BMD referral for DXA using ultrasound as a selective population pre-screen, Technology and Health Care 5 (1997), 235-241.
20. M.F.V. Sim, M. Stone, A. Johansen and W. Evans, Cost effectiveness analysis of BMD referral for DXA using ultrasound as selective pre-screen in a group of women with a low trauma Colles' fractures, Technology and Health Care 8 (2000), 277-284.
21. Report of the Advisory Group on Osteoporosis, Department of Health, London 1994.
22. U.A. Liberman, S.R. Weiss, J. Broll, H.W. Minne, H. Quan, N.H. Bell, J. Rodriguez-Portales, R.W. Downs Jr, J. Dequeker, M. Favus, E. Seeman, R.R. Recker, T. Capizzi, A.C. Santora, A. Lombardi, R. Shah, L.J. Hirsch and D.B. Karpf, Effect of treatment with oral alendronate on bone mineral density and fracture incidence in postmenopausal osteoporosis, New England Journal of Medicine 333 (1995), 1437-1443.
23. D.M. Black, S.R. Cummings, D.B. Karpf et al., Randomized trial of the effect of alendronate on risk of fracture in women with existing vertebral fractures, Lancet 348 (1996), 1535-1541.
24. C.F. Njeh, D. Hans, J. Li, B. Fan, T. Fuerst, Y.Q. He, E. Tsuda-Futami, Y. Lu, C.Y. Wu and H.K. Genant, Comparison of six calcaneal quantitative ultrasound devices: precision and hip fracture discrimination, Osteoporosis International 11 (2000), 1051-1062.